AJNN

Academic Journal of Neuropsychiatry and Neuropsychology (formerly known as the Academic Journal of Neurology and Neurosurgery, e-ISSN:3023-6517), deals with neurology, neurosurgery, psychiatry and clinical psychology accepts articles on these topics. Academic Journal of Neuropsychiatry and Neuropsychology publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

EndNote Style
Index
Original Article
Examining the correlation of CRP, MPV and NLR levels with the severity of stroke in ischemic stroke patients
Aims: The severity of ischemic stroke may vary depending on the values of some biochemical markers. We aimed to investigate the relationship between CRP, MPV and NLR levels and stroke severity in patients presenting to the emergency department with ischemic stroke.
Methods: 159 patients and 160 healthy volunteers who applied to the emergency department with a diagnosis of ischemic stroke were included in the study. CRP, NLR and MPV levels were measured in venous blood samples taken in the emergency department. The relationship between NHISS and CRP, MPV and NLR, which were measured at the time of admission to the emergency department, was examined.
Results: The average CRP value of individuals in the control group was 6.19 ± 6.48, and the average CRP value of individuals in the patient group was 16.79 ± 18.14. Sick individuals have higher CRP values. CRP values show statistically significant differences between patient and control groups (p<0.001). The average NLR value of individuals in the control group was determined as 2.50 ± 1.18, and the average NLR value of individuals in the patient group was determined as 5.74 ± 5.40. NLR values of sick individuals are higher. NLR values show statistically significant differences between patient and control groups (p<0.001). The average MPV value of individuals in the control group was 8.15 ± 0.84, and the average MPV value of individuals in the patient group was 8.57 ± 1.40. MPV values of sick individuals are higher. MPV values show statistically significant differences between patient and control groups (p=0.002).
Conclusion: Ischemic stroke severity varies depending on biochemical markers. More research is needed in terms of changes depending on many biochemical values.


1. Avan A, Digaleh H, Di Napoli M, et al. Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017. BMC Med. 2019;17(1):191. doi:10.1186/s12916-019-1397-3
2. Zhang T, Jiang Y, Zhang S, et al. The association between homocysteine and ischemic stroke subtypes in Chinese: a meta-analysis. Medicine (Baltimore). 2020;99(12):e19467. doi:10.1097/MD.0000000000019467
3. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868-874. doi:10.1038/nature01323
4. Corrado E, Rizzo M, Coppola G, et al. An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb. 2010;17(1):1-11. doi:10.5551/jat.2600
5. Musunuru K, Kral BG, Blumenthal RS, et al. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008;5(10):621-635. doi:10.1038/ncpcardio1322
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973-979. doi:10. 1056/NEJM199704033361401
7. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140. doi:10.1016/S0140-6736(09)61717-7
8. Dong X, Gao J, Zhang CY, Hayworth C, Frank M, Wang Z. Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke. ACS Nano. 2019;13(2):1272-1283. doi: 10.1021/acsnano.8b0657
9. Zhu B, Pan Y, Jing J, et al. Neutrophil counts, neutrophil ratio, and new stroke in minor ischemic stroke or TIA. Neurology. 2018;90(21):e1870- e1878. doi:10.1212/WNL.0000000000005554
10. Farah R, Samra N. Mean platelets volume and neutrophil to lymphocyte ratio as predictors of stroke. J Clin Lab Anal. 2018;32(1):e22189. doi:10. 1002/jcla.22189
11. Cochran KA, Cavallari LH, Shapiro NL, Bishop JR. Bleeding incidence with concomitant use of antidepressants and warfarin. Ther Drug Monit. 2011;33(4):433-438. doi:10.1097/FTD.0b013e318224996e
12. Sansanayudh N, Numthavaj P, Muntham D, et al. Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis. Thromb Haemost. 2015;114(6): 1299-1309. doi:10.1160/TH15-04-0280
13. Zheng M, Chen S, Zhu Y, Gu X. Mean platelet volume: a new predictor of ischaemic stroke risk in patients with nonvalvular atrial fibrillation. BMC Cardiovasc Disord. 2020;20(1):241. doi:10.1186/s12872-020-01525-x
14. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20): 1557-1565. doi:10.1056/NEJMoa021993
15. Sharp FR, Lu A, Tang Y, Millhorn DE. Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab. 2000;20(7):1011-1032. doi:10.1097/00004647-200007000-00001
16. Siesjö BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg. 1992;77(2):169-184. doi:10.3171/jns.1992.77.2.0169
17. Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G. Persistent inflammatory response in stroke survivors. Neurology. 1998; 50(6):1722-1728. doi:10.1212/wnl.50.6.1722
18. Montaner J, Fernandez-Cadenas I, Molina CA, et al. Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis. Stroke. 2006;37(5):1205-1210. doi:10.1161/01.STR.0000217744.89208.4e
19. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke. 1999;30(5):981-985. doi:10. 1161/01.str.30.5.981
20. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001;32(4):917-924. doi:10.1161/ 01.str.32.4.917
21. Rust R, Grönnert L, Schwab ME. Inflammation after stroke: a local rather than systemic response? Trends Neurosci. 2018;41(12):877-879. doi:10.1016/j.tins.2018.09.011
22. Macrez R, Ali C, Toutirais O, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10(5):471-480. doi:10.1016/S1474-4422(11)70066-7
23. Duan Z, Wang H, Wang Z, et al. Neutrophil-lymphocyte ratio predicts functional and safety outcomes after endovascular treatment for acute ischemic stroke. Cerebrovasc Dis. 2018;45(5-6):221-227. doi:10. 1159/000489401
24. Yamamoto Y, Osanai T, Nishizaki F, et al. Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-?. Heart Vessels. 2012;27(6):624-633. doi:10.1007/s00380-011-0214-5
25. Ceulemans AG, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Michotte Y. The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation. 2010;7:74. doi:10.1186/1742-2094-7-74
26. Xu XR, Zhang D, Oswald BE, et al. Platelets are versatile cells: new discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci. 2016;53(6):409-430. doi:10.1080/10408363.2016.1200008
27. Goyal N, Tsivgoulis G, Chang JJ, et al. Admission neutrophil-to-lymphocyte ratio as a prognostic biomarker of outcomes in large vessel occlusion strokes. Stroke. 2018;49(8):1985-1987. doi:10.1161/STROKEAHA.118.021477
28. Gong P, Liu Y, Gong Y, et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. J Neuroinflammation. 2021;18(1):51. doi:10.1186/s12974-021-02090-6
29. Zhu F, Ji Y, Song JH, Huang GX, Zhang YF. Correlations between NLR, NHR, and clinicopathological characteristics, and prognosis of acute ischemic stroke. Medicine (Baltimore). 2023;102(24):e33957. doi:10. 1097/MD.0000000000033957
30. Bath P, Algert C, Chapman N, Neal B; PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004;35(3): 622-626. doi:10.1161/01.STR.0000116105.26237.EC
31. Sadeghi F, Kovács S, Zsóri KS, Csiki Z, Bereczky Z, Shemirani AH. Platelet count and mean volume in acute stroke: a systematic review and meta-analysis. Platelets. 2020;31(6):731-739. doi:10.1080/09537104.2019. 1680826
32. Sarkar RN, Das CK, Bhattacharjee U, Banerjee M. Platelet indices as a marker of severity in non-diabetic, non-hypertensive acute ischemic stroke patients. J Assoc Physicians India. 2018;66(7):40-42.
33. Zheng YY, Wang L, Shi Q. Mean platelet volume (MPV) and platelet distribution width (PDW) predict clinical outcome of acute ischemic stroke: a systematic review and meta-analysis. J Clin Neurosci. 2022;101: 221-227. doi:10.1016/j.jocn.2022.05.019
34. Ludhiadch A, Sulena, Singh S, et al. Genomic variation affecting MPV and PLT count in association with development of ischemic stroke and its subtypes. Mol Neurobiol. 2023;60(11):6424-6440. doi:10.1007/s12035-023-03460-2
35. Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest. 2020; 130(6):2777-2788. doi:10.1172/JCI135530
36. Liesz A, Dalpke A, Mracsko E, et al. DAMP signaling in post-ischemic brain inflammation. Nat Rev Neurol. 2021;17(3):133-149. doi:10.1523/JNEUROSCI.2439-14.2015
37. Jayaraj RL, Azimullah S, Beiram R, Jalal FY, Rosenberg GA. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142. doi:10.1186/s12974-019-1516-2
38. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.00754
39. Wang L, Song Q, Wang C et al. Neutrophil to lymphocyte ratio predicts poor outcomes after acute ischemic stroke: a cohort study and systematic review. J Neurol Sci. 2019;406:116445. doi:10.1016/j.jns. 2019.116445
40. Bian J, Guo S, Huang T et al. CRP as a potential predictor of outcome in acute ischemic stroke. Biomed Rep. 2023;18(2):17. doi:10.3892/br. 2023.1599
41. Laridan E, Denorme F, Desender L, et al. Neutrophil extracellular traps in ischemic stroke thrombi. Ann Neurol. 2020;87(2):223-238.
42. Hunkler HJ, Groß S, Thum T, Bär C. Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration. Cardiovasc Res. 2022; 118(15):3071-3084. doi:10.1093/cvr/cvab335
43. Lyden P, Raman R, Liu L, Emr M, Warren M, Marler J. National Institutes of Health Stroke Scale certification is reliable across multiple venues. Stroke. 2009;40(7):2507-2511. doi:10.1161/STROKEAHA.108.532069
44. Zhang J, Ren Q, Song Y. Prognostic role of neutrophil-lymphocyte ratio in patients with acute ischemic stroke. Medicine (Baltimore). 2017; 96(45):e8624. doi: 10.1097/MD.0000000000008624
45. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(1):148-156. doi:10.1111/j.1538-7836.2009.03584.x
46. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 2007; 21(2):99-111. doi:10.1016/j.blre.2006.06.001
47. Zheng YY, Wang L, Shi Q. MPV predicts clinical outcome of acute ischemic stroke: meta-analysis. J Clin Neurosci. 2022;101:221-227.
Volume 3, Issue 1, 2026
Page : 6-12
_Footer